Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor, Obes Rev, vol.10, pp.403-411, 2009. ,
The impact of phospholipid transfer protein (PLTP) on lipoprotein metabolism, Nutr Metab (Lond), vol.2012, p.75 ,
Phospholipid transfer protein deficiency protects circulating lipoproteins from oxidation due to the enhanced accumulation of vitamin E, J Biol Chem, vol.277, pp.31850-31856, 2002. ,
Plasma phospholipid transfer protein deficiency in mice is associated with a reduced thrombotic response to acute intravascular oxidative stress, Arterioscler Thromb Vasc Biol, vol.30, pp.2452-2457, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02462980
Anti-inflammatory effects of phospholipid transfer protein (PLTP) deficiency in mice, Biochim Biophys Acta, vol.1733, pp.187-191, 2005. ,
Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice, J Lipid Res, vol.49, pp.773-781, 2008. ,
Atheroprotective potential of macrophage-derived phospholipid transfer protein in low-density lipoprotein receptor-deficient mice is overcome by apolipoprotein AI overexpression, Arterioscler Thromb Vasc Biol, vol.26, pp.1572-1578, 2006. ,
PLTP regulates STAT3 and NFkappaB in differentiated THP1 cells and human monocyte-derived macrophages, Biochim Biophys Acta, vol.1813, 2011. ,
Abdominal aortic aneurysm, Lancet, vol.365, pp.1577-1589, 2005. ,
Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler, Thromb Vasc Biol, vol.26, pp.2605-2613, 2006. ,
Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, Circulation, vol.119, pp.2202-2208, 1994. ,
Inflammation, metalloproteinases, and increased proteolysis: an emerging pathophysiological paradigm in aortic aneurysm, Circulation, vol.96, pp.2115-2117, 1997. ,
Abdominal aortic aneurysm as a complex multifactorial disease: interactions of polymorphisms of inflammatory genes, features of autoimmunity, and current status of MMPs, Ann N Y Acad Sci, vol.1085, pp.117-132, 2006. ,
Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm, Arterioscler Thromb Vasc Biol, vol.15, pp.1145-1151, 1995. ,
Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm, Ann Vasc Surg, vol.21, pp.392-401, 2007. ,
Proteolysis of the abdominal aortic aneurysm wall and the association with rupture, Eur J Vasc Endovasc Surg, vol.23, pp.153-157, 2002. ,
Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms, J Clin Invest, vol.110, pp.625-632, 2002. ,
Cellular localization of matrix metalloproteinases in the abdominal aortic aneurysm wall, J Vasc Surg, vol.20, pp.814-820, 1994. ,
, Macrophages in the pathogenesis of atherosclerosis, vol.29, pp.341-355, 2011.
Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells, J Lipid Res, vol.44, pp.1453-1461, 2003. ,
Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development, Arterioscler Thromb Vasc Biol, vol.27, pp.578-586, 2007. ,
Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms, J Clin Invest, vol.105, pp.1641-1649, 2000. ,
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice, J Clin Invest, vol.105, pp.1605-1612, 2000. ,
Mouse models of abdominal aortic aneurysms, Arterioscler Thromb Vasc Biol, vol.24, pp.429-434, 2004. ,
Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels, J Clin Invest, vol.103, pp.907-914, 1999. ,
Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate, J Biol Chem, vol.276, pp.25841-25847, 2001. ,
Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene, Biochem Biophys Res Commun, vol.287, pp.921-926, 2001. ,
A: Fenofibrate reverses the decline in HDL cholesterol in mice overexpressing human phospholipid transfer protein, Biochim Biophys Acta, vol.1738, pp.48-53, 2005. ,
Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms, Nat Med, vol.15, pp.649-656, 2009. ,
Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression, PLoS One, vol.7, p.51707, 2012. ,
Antagonism of AT2 receptors augments angiotensin II-induced abdominal aortic aneurysms and atherosclerosis, Br J Pharmacol, vol.134, pp.865-870, 2001. ,
Abdominal aortic aneurysms: fresh insights from a novel animal model of the disease, Vasc Med, vol.7, pp.45-54, 2002. ,
Human seminal plasma displays significant phospholipid transfer activity due to the presence of active phospholipid transfer protein, Mol Hum Reprod, vol.9, pp.457-464, 2003. ,
, Elastase-induced experimental aneurysms in rats. Circulation, vol.82, pp.973-981, 1990.
The elastase infusion model of experimental aortic aneurysms: synchrony of induction of endogenous proteinases with matrix destruction and inflammatory cell response, J Vasc Surg, vol.20, pp.51-60, 1994. ,
Chronic inflammation, immune response, and infection in abdominal aortic aneurysms, Eur J Vasc Endovasc Surg, vol.31, pp.453-463, 2006. ,
PLTP deficiency improves the anti-inflammatory properties of HDL and reduces the ability of LDL to induce monocyte chemotactic activity, J Lipid Res, vol.45, pp.1852-1858, 2004. ,
Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-kappaB, J Vasc Surg, vol.41, pp.479-489, 2005. ,
Urokinase-type plasminogen activator deficiency in bone marrowderived cells augments rupture of angiotensin II-induced abdominal aortic aneurysms, Arterioscler Thromb Vasc Biol, vol.31, pp.2845-2852, 2011. ,
Inhibition of Notch1 signaling reduces abdominal aortic aneurysm in mice by attenuating macrophage-mediated inflammation, Arterioscler Thromb Vasc Biol, vol.32, pp.3012-3023, 2012. ,
Inhibition of soluble epoxide hydrolase attenuated atherosclerosis abdominal aortic aneurysm formation, and dyslipidemia, Arterioscler Thromb Vasc Biol, vol.29, pp.1265-1270, 2009. ,
Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency ,
, Nat Med, vol.7, pp.847-852, 2001.
Phospholipid transfer protein-deficient mice absorb less cholesterol, Arterioscler Thromb Vasc Biol, vol.27, 2007. ,
Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism, Science, vol.332, pp.361-365, 2011. ,
AT1A(-/-) double knock out mice, Stimulation of the AT2 receptor reduced atherogenesis in ApoE, vol.52, pp.630-637, 2012. ,
HDL antielastase activity prevents smooth muscle cell anoikis, a potential new antiatherogenic property, FASEB J, vol.23, pp.3129-3139, 2009. ,
LDL size and subclasses in patients with abdominal aortic aneurysm, Int J Cardiol, vol.134, pp.406-408, 2009. ,
Novel insight into the pathobiology of abdominal aortic aneurysm and potential future treatment concepts, Prog Cardiovasc Dis, vol.50, pp.209-217, 2007. ,
Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease, Biochim Biophys Acta, vol.1762, pp.131-137, 2006. ,
High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease, Arterioscler Thromb Vasc Biol, vol.23, pp.1857-1862, 2003. ,
Serum phospholipid transfer protein mass as a possible protective factor for coronary heart diseases, Circ J, vol.68, pp.11-16, 2004. ,
Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis, Atherosclerosis, vol.196, pp.219-226, 2008. ,
Potential circulating biomarkers for abdominal aortic aneurysm expansion and ruptureea systematic review, Eur J Vasc Endovasc Surg, vol.36, pp.273-280, 2008. ,